SMOC1 and familial pancreatic carcinoma: Our study has certain limitations, including lack of clinical sample validation, and deep mechanistic study, such as observing the effect of altering the effect of the OAS family gene(s) expression in pancreatic cancer cells by invasion and colony forming assays, and manipulating the OAS family gene(s) in pancreatic cancer cells on their pro- and anti-inflammatory cytokine release profile, due to campus lockdown in the COVID-19 epidemic season.